155 related articles for article (PubMed ID: 9116293)
1. Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel MG; Reaman GR
Blood; 1997 Apr; 89(7):2488-93. PubMed ID: 9116293
[TBL] [Abstract][Full Text] [Related]
2. CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Uckun FM; Steinherz PG; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
Blood; 1996 Dec; 88(11):4288-95. PubMed ID: 8943865
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Uckun FM; Gaynon PS; Sensel MG; Nachman J; Trigg ME; Steinherz PG; Hutchinson R; Bostrom BC; Sather HN; Reaman GH
J Clin Oncol; 1997 Jun; 15(6):2214-21. PubMed ID: 9196133
[TBL] [Abstract][Full Text] [Related]
7. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues.
Uckun FM; Muraguchi A; Ledbetter JA; Kishimoto T; O'Brien RT; Roloff JS; Gajl-Peczalska K; Provisor A; Koller B
Blood; 1989 Mar; 73(4):1000-15. PubMed ID: 2784064
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
9. Characterization of leukemic cells in CD2/CD19 double positive acute lymphoblastic leukemia.
Manabe A; Mori T; Ebihara Y; Koyama T; Okuyama I; Hosoya R; Kaneko M; Ishimoto K; Nakahata T; Nakazawa S
Int J Hematol; 1998 Jan; 67(1):45-52. PubMed ID: 9594444
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression.
Cantù-Rajnoldi A; Putti MC; Schirò R; Biondi A; Cattoretti G; Valeggio C; Castagni M; Basso G
Haematologica; 1992; 77(5):384-91. PubMed ID: 1362385
[TBL] [Abstract][Full Text] [Related]
11. CD2 + CD19 + acute lymphoblastic leukaemia in 16 children and adults: clinical and biological features. Groupe d'Etude Immunologique des Leucémies (G.E.I.L.).
Lenormand B; Vannier JP; Bene MC; Falkenrodt A; Bayle C; Favre M; Garand R; Griveau AM; Briquet MT; Reman O
Br J Haematol; 1993 Apr; 83(4):580-8. PubMed ID: 7686033
[TBL] [Abstract][Full Text] [Related]
12. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
13. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
14. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
15. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Stock W; La M; Sanford B; Bloomfield CD; Vardiman JW; Gaynon P; Larson RA; Nachman J; ;
Blood; 2008 Sep; 112(5):1646-54. PubMed ID: 18502832
[TBL] [Abstract][Full Text] [Related]
16. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
[TBL] [Abstract][Full Text] [Related]
17. Peroxidase-negative and myelomonocytic antigen-positive acute leukemia.
Okawa H; Nagasawa M; Morio T; Takase K; Tanaka K; Yata J; Dan K; Nomura T; Sakamaki H; Onozawa Y
Int J Hematol; 1992 Apr; 55(2):165-71. PubMed ID: 1324747
[TBL] [Abstract][Full Text] [Related]
18. Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Uckun FM; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Blood; 1997 May; 89(10):3769-77. PubMed ID: 9160683
[TBL] [Abstract][Full Text] [Related]
19. Lineage Switch in MLL-Rearranged Infant Leukemia Following CD19-Directed Therapy.
Rayes A; McMasters RL; O'Brien MM
Pediatr Blood Cancer; 2016 Jun; 63(6):1113-5. PubMed ID: 26914337
[TBL] [Abstract][Full Text] [Related]
20. [Immunophenotyping of leukemic stem cells and chromosome karyotype characteristics in Uyghur leukemia pediatric patients].
Hailiqiguli N; Yan M
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):501-4. PubMed ID: 24257300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
